Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Open Access
- 20 March 2012
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 21 (3), 297-308
- https://doi.org/10.1016/j.ccr.2012.02.014
Abstract
No abstract availableThis publication has 151 references indexed in Scilit:
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B CellsCell Metabolism, 2012
- Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopyJournal of Neuro-Oncology, 2011
- Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 SignalingCancer Cell, 2011
- Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1Cell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic TransformationCancer Cell, 2010
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-HydroxyglutarateCancer Cell, 2010
- Use of a novel method to find substrates of protein kinase C delta identifies M2 pyruvate kinaseThe International Journal of Biochemistry & Cell Biology, 2007